日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Physician attitudes and system factors associated with non-medically indicated cesarean sections in Thailand: a prospective implementation study

泰国医生态度及与非医学指征剖宫产相关的系统因素:一项前瞻性实施研究

Titapant, Vitaya; Chawanpaiboon, Saifon; Kanjanapongporn, Attapol; Pooliam, Julaporn; Anuwutnavin, Sanitra

Effect of Nipple Shield Use on Exclusive Breastfeeding up to 6 Months in Mothers with Nipple Abnormalities: A Randomized Controlled Trial

乳头保护罩对乳头异常母亲纯母乳喂养至6个月的影响:一项随机对照试验

Chawanpaiboon, Saifon; Anuwutnavin, Sanitra; Pooliam, Julaporn

Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 (0) and 36 (6) weeks of gestation: study protocol

一项双盲、非劣效性、随机对照试验,评估地塞米松4、5和6 mg在预防妊娠29(0)周至36(6)周极早产至晚期早产妊娠不良新生儿和孕产妇结局方面的疗效:研究方案

Chawanpaiboon, Saifon; Wutthigate, Punnanee; Anuwutnavin, Sanitra; Sutchritpongsa, Sureelak

Attitudes, Perceptions and Determinants of Non-Medically Indicated Caesarean Section Preference Among Pregnant Women in Thailand: A Three-Phase Mixed-Methods Study

泰国孕妇对非医学指征剖宫产的态度、认知及决定因素:一项三阶段混合方法研究

Chawanpaiboon, Saifon; Anuwutnavin, Sanitra; Titapant, Vitaya; Kanjanapongporn, Attapol; Pooliam, Julaporn; Srichai, Rangsima

Impact of isolated fetal congenital heart disease on pregnancy and perinatal outcomes

孤立性胎儿先天性心脏病对妊娠和围产期结局的影响

Kittiratanapinan, Yossawadee; Anuwutnavin, Sanitra; Kanjanauthai, Supaluck; Wutthigate, Punnanee; Boriboonhirunsarn, Dittakarn; Chawanpaiboon, Saifon

Comparing three cardiothoracic ratio measurement techniques and creating multivariable scoring system to predict Bart's hydrops fetalis at 17-22 weeks' gestation

比较三种心胸比测量技术,并建立多变量评分系统以预测妊娠17-22周的巴特氏胎儿水肿

Anuwutnavin, Sanitra; Rangseechamrat, Patsawee; Sompagdee, Nalat; Ruangvutilert, Pornpimol; Viboonchard, Sommai

Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines

母体接种不同剂量的重组百日咳疫苗后,母体抗体可在产后两个月内有效且安全地转移给婴儿。

Chokephaibulkit, Kulkanya; Puthanakit, Thanyawee; Chaithongwongwatthana, Surasith; Bhat, Niranjan; Tang, Yuxiao; Anugulruengkitt, Suvaporn; Chayachinda, Chenchit; Anuwutnavin, Sanitra; Lapphra, Keswadee; Rungmaitree, Supattra; Tawan, Monta; Andi-Lolo, Indah; Holt, Renee; Fortuna, Librada; Kerdsomboon, Chawanee; Yuwaree, Vilasinee; Mansouri, Souad; Thai, Pham Hong; Innis, Bruce L

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women

异源性新冠疫苗在孕妇中的免疫原性和反应原性

Chayachinda, Chenchit; Watananirun, Kanokwaroon; Phatihattakorn, Chayawat; Anuwutnavin, Sanitra; Niyomnaitham, Suvimol; Phongsamart, Wanatpreeya; Lapphra, Keswadee; Wittawatmongkol, Orasri; Rungmaitree, Supattra; Jansarikit, Laddawan; Boonnak, Kobporn; Wongprompitak, Patimaporn; Senawong, Sansnee; Upadhya, Avishek; Toh, Zheng Quan; Licciardi, Paul V; Chokephaibulkit, Kulkanya

A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women

一项针对孕妇的含有基因灭活百日咳毒素的重组百日咳加强疫苗的2期随机对照剂量范围试验

Puthanakit, Thanyawee; Chokephaibulkit, Kulkanya; Chaithongwongwatthana, Surasith; Bhat, Niranjan; Tang, Yuxiao; Anugulruengkitt, Suvaporn; Chayachinda, Chenchit; Anuwutnavin, Sanitra; Lapphra, Keswadee; Rungmaitree, Supattra; Tawan, Monta; Andi-Lolo, Indah; Holt, Renee; Fortuna, Librada; Kerdsomboon, Chawanee; Yuwaree, Vilasinee; Mansouri, Souad; Thai, Pham Hong; Innis, Bruce L